Glaukos (NYSE:GKOS) announced today that the FDA approved its Epoxia incision-free alternative to corneal cross-linking ...

The US Food and Drug Administration (FDA) has approved Glaukos Corporation’s Epioxa, offering patients living with a rare ...

Glaukos’ Epioxa allows cross-linking therapy for keratoconus without requiring an incision. The biotech expects to launch the ...

Glaukos announced that the FDA has approved the new drug application for its topical drug therapy (Epioxa HD/Epioxa) for keratoconus. 1,2 This approval makes it the first FDA-approved corneal ...

The advancements of minimally invasive cardiac surgery for seniors often give them a better chance for a speedy recovery, as ...

Glaukos Corp. today announced it received FDA approval for Epioxa, an eye therapy made to stop the progression of keratoconus.

The 367-page-long book contains detailed accounts of Giuffre's encounters with Jeffrey Epstein, Ghislaine Maxwell and Prince ...

Epioxa is the first epithelium-on cross-linking procedure approved in the U.S. Glaukos plans for Epioxa to be commercially ...

Minimally invasive endoscopic surgery may be an effective and safe treatment for patients with intracerebral hemorrhage, the ...

Should I have my cat neutered? But what exactly happens during the procedure, when is the right time, and what persistent ...

Samsara Vision Expands U.S. and Puerto Rico Clinical Study Sites for the Smaller-Incision New-Generation Implantable ...